We are very pleased that the convincing data on Oncoteq’s #TEQ102, former TUB-010, by partner and inventor, Tubulis GmbH, has been published. Please check it out and don’t hesitate to reach out. Link to publication below:

https://aacrjournals.org/mct/article-abstract/doi/10.1158/1535-7163.MCT-25-0062/764236/TUB-010-a-novel-anti-CD30-antibody-drug-conjugate?redirectedFrom=fulltext